Pyridium is a brand-name medication whose active ingredient is phenazopyridine. It belongs to the category of urological health agents that are used to relieve discomfort associated with irritation of the urinary tract. Pyridium is supplied as a 200 mg oral pill. In Hong Kong the product is classified as a prescription medication and is regulated by the Hong Kong Department of Health.
Phenazopyridine acts as a local analgesic on the mucosa of the urinary tract. After oral absorption, the drug is excreted unchanged in the urine, where it binds to sensory nerve endings lining the bladder, urethra and ureters. This binding reduces the perception of pain, burning, urgency and frequency that commonly accompany urinary tract irritation.
Because phenazopyridine is not an antimicrobial, it does not treat the underlying infection; it merely eases the symptoms while the infection is being managed with appropriate antibiotics.
Pyridium is approved to provide symptomatic relief of urinary discomfort caused by:
It is intended for short-term use, generally no longer than two days unless specifically directed by a healthcare professional.
If any of these conditions apply, the prescriber should evaluate risk versus benefit before initiating therapy.
These effects are usually transient and do not require medical intervention.
Any of the above warrant immediate medical attention.
Patients should always provide a complete medication list-including over-the-counter drugs, supplements and herbal products-before starting Pyridium.
This article provides educational information about Pyridium and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Phenazopyridine may cause a harmless discoloration of urine but does not contain substances that trigger standard illicit-drug screening assays. However, laboratory personnel should be informed of recent phenazopyridine use to avoid misinterpretation of urine colour.
The urine will appear bright orange-red, similar to a dilute sunset hue. This colour change is a normal pharmacologic effect and does not indicate kidney damage or infection. It resolves within 24-48 hours after the last dose.
Pyridium sold in Hong Kong contains 200 mg phenazopyridine per tablet, identical to the formulation approved in many other markets. Packaging designs, imprint codes, and excipients may vary by manufacturer, but the active ingredient strength remains consistent.
No. In Hong Kong the medication is classified as prescription-only and must be dispensed by a registered pharmacist upon presentation of a qualified prescription.
Yes, provided you carry the medication in its original labelled container with a copy of the prescription. Some countries may request documentation for prescription-only drugs, so keep the prescribing information handy at airport security.
Unopened tablets retain their potency until the printed expiry date, typically two to three years from the manufacturing date when stored as directed. Do not use tablets past this date.
Brand-named Pyridium may be priced higher due to branding and packaging. Generic phenazopyridine tablets of the same 200 mg strength are generally less expensive, though exact prices vary by pharmacy and bulk purchasing agreements.
There are no known major interactions with standard multivitamins. However, supplements containing high doses of vitamin C or other oxidising agents could theoretically increase the risk of methemoglobinemia; discuss all supplements with your healthcare provider.
Doubling a dose is not recommended. Take the missed tablet as soon as you remember, unless the next scheduled dose is within a few hours, in which case skip the missed dose and resume the regular timing.
Prolonged use increases the risk of serious adverse events such as hemolytic anemia and methemoglobinemia. It is intended solely for short-term symptom relief while definitive treatment (e.g., antibiotics) addresses the underlying cause.
